These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

• J1445

  Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron

• J1446

  Injection, tbo-filgrastim, 5 micrograms

• J1447

  Injection, tbo-filgrastim, 1 microgram

• J1448

  Injection, trilaciclib, 1mg

• J1449

  Injection, eflapegrastim-xnst, 0.1 mg

• J1450

  Injection fluconazole, 200 mg

• J1451

  Injection, fomepizole, 15 mg

• J1452

  Injection, fomivirsen sodium, intraocular, 1.65 mg

• J1453

  Injection, fosaprepitant, 1 mg

• J1454

  Injection, fosnetupitant 235 mg and palonosetron 0.25 mg

• J1455

  Injection, foscarnet sodium, per 1000 mg

• J1456

  Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg

• J1457

  Injection, gallium nitrate, 1 mg

• J1458

  Injection, galsulfase, 1 mg

• J1459

  Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg

• J1460

  Injection, gamma globulin, intramuscular, 1 cc

• J1551

  Injection, immune globulin (cutaquig), 100 mg

• J1552

  Injection, immune globulin (alyglo), 500 mg

• J1553

  Injection, immune globulin (yimmugo), 100 mg

• J1554

  Injection, immune globulin (asceniv), 500 mg

• J1555

  Injection, immune globulin (cuvitru), 100 mg

• J1556

  Injection, immune globulin (bivigam), 500 mg

• J1557

  Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg

• J1558

  Injection, immune globulin (xembify), 100 mg

• J1559

  Injection, immune globulin (hizentra), 100 mg

• J1560

  Injection, gamma globulin, intramuscular, over 10 cc

• J1561

  Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg

• J1562

  Injection, immune globulin (vivaglobin), 100 mg

• J1566

  Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg

• J1568

  Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg

• J1569

  Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg

• J1570

  Injection, ganciclovir sodium, 500 mg

• J1571

  Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml

• J1572

  Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg

• J1573

  Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml

• J1574

  Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg

• J1575

  Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin

• J1576

  Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg

• J1580

  Injection, garamycin, gentamicin, up to 80 mg

• J1590

  Injection, gatifloxacin, 10 mg

• J1595

  Injection, glatiramer acetate, 20 mg

• J1596

  Injection, glycopyrrolate, 0.1 mg

• J1597

  Injection, glycopyrrolate (glyrx-pf), 0.1 mg

• J1598

  Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg

• J1599

  Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg

• J1600

  Injection, gold sodium thiomalate, up to 50 mg

• J1602

  Injection, golimumab, 1 mg, for intravenous use

• J1610

  Injection, glucagon hydrochloride, per 1 mg

• J1611

  Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg

• J1612

  Injection, glucagon (gvoke), 0.01 mg

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/3/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.